Bookmark this lesson
Login or create an account to save and access your bookmarks
Bookmark this lesson
Login or create an account to save and access your bookmarks
Not yet registered?
What you can access by simply creating a account:
Register today to get the most out of the education academy. Save your progress, bookmarks lessons, track your progress plus more...
Save your progress in this lesson so you can pick it up where you left off.
Add lessons to your bookmarks so you can quickly return to them in the future.
Track your progress throughout the course to see what you have achieved.
Treatment specialists
Meet some of the specialists who may be involved in your care and how they work together.
Gastroenterologists
A gastroenterologist helps confirm pancreato-biliary IgG4-RD, treats blockages, and coordinates your treatment.
When IgG4-RD affects the pancreas and bile ducts
Why a GI specialist may be a part of your team
When IgG4-related disease (IgG4-RD) involves the pancreas or bile ducts, a gastroenterologist (GI doctor) often becomes one of your most important guides. Gastroenterologists care for the digestive system, and many also specialize in the liver and bile ducts. They can use advanced imaging and endoscopic procedures to look closely at the pancreas and bile ducts, take tissue samples when safe, and relieve blockages without surgery. Because of the high frequency of involvement of the pancreas and bile ducts, gastroenterologists are often the primary point of care for patients with IgG4-RD.
In IgG4‑RD, the pancreas and bile ducts are common targets. That’s why many people with new jaundice (yellow eyes/ skin), dark urine, pale or clay-colored stools, itching, abdominal pain, major weight loss, or new-onset diabetes first meet a GI doctor in the emergency room or clinic.
A GI doctor’s job is to sort out what is happening, control the inflammation in the pancreas, liver, and bile duct, attend to any obstructed bile ducts that may require the temporary placement of biliary stents, and help the rest of the care team plan safe treatment. 1,3
Fireside Chat: “The Pancreas and Bile Ducts in IgG4-RD”
In this IgG4ward Fireside Chat video, Dr. Emma Culver and Dr. Emanuel Della Torre explain why gastroenterology matters so much: nearly 40% of people with IgG4-RD develop autoimmune pancreatitis, and about 60% of those may also have IgG4- related cholangitis (bile-duct inflammation).
The pancreas and bile ducts functions
Pancreas: an organ behind the stomach that helps digest food and helps regulate blood sugar.
Bile ducts: thin tubes that carry bile from the liver into the intestine to help digest fats. In IgG4‑RD, inflammation can cause swelling and scarring in these areas. When the common bile duct or the area where the bile duct meets the pancreas becomes narrowed, bile cannot flow normally.
That backup can cause jaundice (yellow eyes/skin), itching, dark urine, and pale or clay-colored stools. Pancreatitis leads to pancreatic swelling and narrowing of the pancreatic duct. As a result, digestive enzymes secreted by the pancreas don’t make it into the intestine and the ability of the pancreas to produce such enzymes becomes impaired. A stent into the pancreatic duct may be a temporary requirement to restore flow from the pancreatic duct.
What symptoms bring people to GI care
People often meet a GI doctor because symptoms feel urgent or concerning, especially when the bile duct is blocked. Common symptoms and signs that can show up when the pancreas and bile ducts are involved: abdominal pain, fatigue, jaundice, itching, stool changes, and weight loss (sometimes related to malabsorption or blood-sugar changes).
[insert diagram]
What it looks like
Imagine your bile ducts as a set of flexible straws. In IgG4‑RD, the wall of a straw can thicken and tighten from the inside. The opening narrows—like pinching the straw—so fluid can’t pass. The backup is what causes jaundice, dark urine, and pale stools.
Patient shares his story
Fred describes how symptoms of jaundice from a bile duct blockage initially led doctors to suspect pancreatic or bile duct cancer and plan a major Whipple surgery, but further testing revealed IgG4-related disease instead, allowing him to receive treatment and participate in clinical research that helped advance understanding of the condition.
Why IgG4-RD can be confused with cancer
IgG4-RD can form tumor-like swellings (doctors call them “tumefactive lesions”) in the pancreas.
On scans, these can look like pancreatic cancer or bile-duct cancer. Blood tests may not be able to differentiate cancer from IgG4-RD. Even the symptoms—jaundice, weight loss, abdominal pain—overlap. A classic presentation of pancreatic cancer and other malignancies in the porta hepatis ( “gate to the liver”, the place where different bile ducts converge) region is painless jaundice—and this is precisely the way that IgG4-RD often presents, too.
When confronted with the challenge of differentiating IgG4-RD f rom cancer, gastroenterologists sometimes employ a short steroid “trial”. A month of prednisone at 40 mg/day will have a substantial effect on IgG4-RD and improvements over the course of a month can be appreciated by serial imaging studies. If a lesion in the pancreas or porta hepatis fails to improve radiologically after one month of prednisone, then a biopsy will be required to exclude malignancy with greater certainty.
A GI doctor may perform ERCP (a camera ‑ guided test into the bile ducts) or endoscopic ultrasound with a small needle to sample tissue. The pathologist looks for a pattern th at fits IgG4-RD, not cancer. When a biopsy isn’t possible, doctors pull together all the clues from imaging, blood tests, and how you respond to treatment to make the best plan. 1-3
Track GI symptoms with the IgG4ME! App
Keep your IgG4-RD story organized in one place. Track your history, labs, and care team so you can share what matters when it matters most.
Get the appHow biliary mass can be wrongly diagnosed as cancer
Dr. Bertus Eksteen, a gastroenterologist and Associate Professor of Medicine at the University of Calgary, discusses how IgG4-related disease in the porta hepatis frequently presents as a tumor mass, mimicking cancer, and can be wrongly diagnosed as a malignancy on imaging.
What gastroenterologists do for IgG4-RD
Gastroenterologists play a hands‑on role in IgG4‑RD by using imaging and specialized procedures to confirm the diagnosis and rule out serious conditions that can look similar.
1. Diagnose and “rule out” dangerous look-alikes
GI specialists help interpret imaging and may use endoscopic ultrasound (EUS) or ERCP to obtain samples when it’s safe and useful, especially when cancer is a concern. GI specialists help separate IgG4-RD from cancer, infection, gallstones, and other causes.
Imaging: Ultrasound, CT, MRCP (MRI of bile ducts), and endoscopic ultrasound help define the blockage or swelling.
Endoscopy: With ERCP, the GI doctor can look into the bile duct, inject contrast dye for X‑ray pictures, and sometimes take brushings or tiny biopsies.
2. Relieve blockage quickly (often with endoscopy and stents)
If jaundice and itching are coming from a narrowed bile duct, GI doctors may use ERCP to place a small stent that reopens drainage. Stenting may sometimes be paired with medicines that support bile flow, such as ursodeoxycholic acid, depending on the situation
Biliary stenting: During ERCP, the doctor can place a small stent (tube) across a narrowed or blocked duct to let bile flow again. This often makes jaundice and itching improve within days.
Dilation: If a short segment is tight, they may gently stretch it.
3. Partner on medical treatment
GI specialists work closely with rheumatologists on a stepwise treatment plan to control inflammation and prevent it from coming back. This treatment “ladder” may include:
Steroids to calm inflammation
B-cell depletion therapy for selected patients and relapse prevention
Maintenance therapy strategies to reduce recurrence
4. Help restore function and nutrition
Pancreatic involvement can reduce enzyme output and impair nutrient absorption, so GI teams often support digestion and metabolism.
Enzyme replacement: Pancrelipase products may be used to improve digestion and stabilize weight. These pills, taken with each meal simply replace the enzymes that a normal pancreas makes.
Nutrition/metabolic support: Fat-soluble vitamins (A, D, E, K) may be monitored/repleted, and diabetes care coordinated if needed.
5. Watch for longer-term complications
Over time, ongoing inflammation can lead to scarring, and in some cases stones or calcifications in the pancreatic ducts, which may require additional endoscopic procedures to relieve blockages.
Follow-up helps confirm inflammation stays controlled and catches mechanical or scarring-related problems early.
Who with IgG4-RD should see a gastroenterologist?
You’ll likely see a GI specialist if you have any of the following with suspected or known IgG4‑RD:
Jaundice, dark urine, pale stools, or itching (signs of bile‑duct blockage)
Abdominal pain, nausea, weight loss, or suspected pancreatitis
A mass or narrowing seen on imaging in the pancreas or bile ducts
New-onset diabetes with pancreatic changes on imaging
Need for ERCP, endoscopic ultrasound, or a biliary stent
Your rheumatologist may also refer you to GI to help confirm the diagnosis when the pancreas or bile ducts are involved, or to manage stents and follow-up after treatment.
Summary
IgG4-RD often involves the pancreas and bile ducts. Gastroenterologists play a central role in diagnosing the problem, opening blocked ducts with ERCP and stents, partnering on medical therapy (steroids and B‑cell–directed treatments), and monitoring over time. Their early involvement can prevent unnecessary major surgery, relieve symptoms quickly, and protect organ function.
References
1. Stone JH, Zen Y, Deshpande V. IgG4‑Related Disease. N Engl J Med. 2012;366:539–551. https://www.nejm.org/doi/10.1056/NEJMra1104650
2. Peyronel F, Della‑Torre E, Maritati F, et al. IgG4‑related disease and other fibro‑inflammatory conditions. Nat Rev Rheumatol. 2025;21:275–290. https://doi.org/10.1038/s41584-025-01240-x
3. Lang D, Zwerina J, Pieringer H. IgG4‑related disease: current challenges and future prospects. Ther Clin Risk Manag. 2016;12:189–199. https://pmc.ncbi.nlm.nih.gov/articles/PMC4760655/
Track GI symptoms and more
Track your symptoms, appointments, medications and more, with the IgG4ME! smartphone app.
Download app now